Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II
Overview
Cardiol Therapeutics (NASDAQ:CRDL,TSX:CRDL) is a clinical-stage life sciences company focused on the…
Read More...
Read More...
Finance News